Naresh Bumma
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 52
- Multiple Myeloma Research and Treatments 46
- Chronic Myeloid Leukemia Treatments 7
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 16
- Protein Degradation and Inhibitors 13
- Co-authors
- Jeffrey A. Zonder (14 shared papers)Hans C. Lee (9 shared papers)Seongho Kim (7 shared papers)Abdullah Khan (27 shared papers)Ulka N. Vaishampayan (4 shared papers)Ghayathri Jeyakumar (4 shared papers)Srinivas Devarakonda (26 shared papers)Elisabeth I. Heath (3 shared papers)
- Journals
- Blood (18 papers)Journal of Clinical Oncology (9 papers)Biology of Blood and Marrow Transplantation (3 papers)HemaSphere (3 papers)Journal of Clinical Medicine (2 papers)
- Partner nations
- United StatesBelgiumIndia
In The Last Decade
Naresh Bumma
62 papers receiving 545 citations
Peers
Comparison fields: 5 of 51
- Hematology 226
- Oncology 266
- Genetics 102
- Nephrology 64
- Molecular Biology 290
Countries citing papers authored by Naresh Bumma
This map shows the geographic impact of Naresh Bumma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naresh Bumma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naresh Bumma more than expected).
Fields of papers citing papers by Naresh Bumma
This network shows the impact of papers produced by Naresh Bumma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naresh Bumma. The network helps show where Naresh Bumma may publish in the future.
Co-authors
The 25 scholars most cited alongside Naresh Bumma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 138 | |
| 2 | 2017 | 80 | |
| 3 | 2018 | 39 | |
| 4 | 2023 | 37 | |
| 5 | 2022 | 29 | |
| 6 | 2021 | 27 | |
| 7 | 2019 | 16 | |
| 8 | 2021 | 12 | |
| 9 | 2021 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2019 | 9 | |
| 12 | 2015 | 9 | |
| 13 | 2022 | 8 | |
| 14 | 2022 | 8 | |
| 15 | 2023 | 8 | |
| 16 | 2022 | 6 | |
| 17 | 2017 | 6 | |
| 18 | 2019 | 6 | |
| 19 | 2019 | 6 | |
| 20 | 2023 | 5 |
About Naresh Bumma
Naresh Bumma is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Epidemiology, having authored 70 papers that have together received 557 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (46 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers), Protein Degradation and Inhibitors (13 papers), Peptidase Inhibition and Analysis (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Hematology (226 citations), Oncology (266 citations), Genetics (102 citations), Nephrology (64 citations) and Molecular Biology (290 citations). Naresh Bumma has collaborated with scholars based in United States, Belgium and India. Frequent co-authors include Jeffrey A. Zonder, Hans C. Lee, Seongho Kim, Abdullah Khan, Ulka N. Vaishampayan, Ghayathri Jeyakumar, Srinivas Devarakonda, Elisabeth I. Heath, Brenda Dickow and Yvonne A. Efebera. Their work appears in journals such as Blood, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation, HemaSphere and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.